Both in Biotechnology
Scilex Holding vs TScan Therapeutics
Over the past year SCLX returned −89.6% and TCRX returned −84.8%; their daily moves had a correlation of 0.19.
SCLX −89.6% TCRX −84.8%Growth of $1, one year, split-adjusted
| Metric | SCLX | TCRX |
|---|---|---|
| Price | $1.85 | $0.1890 |
| Market cap | $13.0M | $12.8M |
| Today | −1.07% | +5.47% |
| 1 month | −51.6% | −36.0% |
| 6 months | −82.8% | −84.4% |
| Year to date | −84.8% | −81.1% |
| 1 year | −88.8% | −90.3% |
| Revenue growth (YoY) | −22.8% | −65.8% |
| Gross margin | 51.9% | 100.0% |
| Net margin | −1501.3% | −2888.6% |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | 1.8× |
| Net cash | -$82.5M | $67.4M |
| Dividend yield | — | — |
| Volatility (60d) | 70.3% | 140.8% |
| Short % of float | 2.4% | 4.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).